Latin Resources firms up its Westminster holding

|

Published 13-MAY-2021 15:28 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Latin Resources (ASX:LRS) announced today that is maintaining its shareholder position in Westminster Resources (TSX-V: WMR).

LRS has subscribed for 2,700,000 shares (CAD540,000) in a Private Placement to be completed by the TSX Venture Exchange listed Westminster.

Once the placement closes, LRS will have a 24% holding.

Funds from the placement will be used to further develop Westminster’s copper project portfolio in Latin America including the newly acquired Mostazal Copper project, its copper projects in Peru acquired from Latin Resources, and for general corporate and working capital purposes.

The project has known copper mineralization that occurs in a series of stacked stratified lenses measuring 2.5km long by 2km wide and 300m deep.

Reported historical production of 120,000 tons has been processed with an average grade of 1.8% Cu1.

“We congratulate Westminster team on the successful placement to fund the development of the exciting Mostazal Copper project in one of the world’s premier Copper districts,” Latin Resources’ Executive Director, Chris Gale said.

“Latin Resources are strongly supportive of the well-structured and well-timed acquisition Westminster has made of the Mostazal Copper Project in Chile, with the outlook for copper being so robust. We look forward to seeing the WMR team advance the project where they can now commence exploration, targeting a large-scale copper porphyry system, underlying the already delineated higher grade copper mineralisation at surface”.

The Mostazal copper Project is located in the Atacama Desert of Chile, 80 km northeast of Copiapo, 30 km east of Inca de Oro. The property consists of eight exploitation licenses covering approximately 16 square kms within the main porphyry copper belt of Chile, along the Domeyko Fault System.

Mostazal Project Location map, Region III Chile, South America.

The Domeyko Fault - Northern Chile is among the most productive copper regions in the world, hosting a significant number of copper porphyry deposits. The Domeyko Fault System is a 500-kilometre corridor, intersected by cross-cutting structures at Mostazal, with significant copper mineralisation exposed at surface, and drilled to a shallow depth.

Westminster has interpreted a porphyry copper deposit beneath the existing mineralisation and geochemical/geophysical anomalies due to:

  • Proximity along the Domeyko Fault
  • Same longitude and elevation as Codelco’s El Salvador Copper Mine
  • Similar lithology and Upper Eogene age as El Salvador
  • Significant copper mineralisation over an area of 15km2
  • Untested rock geochemical anomalies
  • Classic IP/Magnetics geophysical porphyry signature

Westminster is in the process of reviewing data from a 2012 – 2013 exploration program conducted by a prior operator at Mostazal.

“Mineralization at surface bears all the hallmarks of an extension to a buried porphyry copper system, including tell-tale alteration halo, and the suite of copper sulphides and associated pathfinder elements you’d expect to see,” Jason Cubitt, Westminster’s President and CEO said.

“It’s highly encouraging to see the geophysical modelling of structures of significant size at depth lying beneath known copper mineralization at surface.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X